Effects of GAG Therapy on Urothelial Barrier and Repair
摘要
Purpose of review
This review summarizes the rationale as well as published data for GAG substitution therapy in chronic bladder diseases, primarily in bladder pain syndrome/interstitial cystitis (BPS/IC).
Recent findingsThe beneficial effect of GAG substitution therapy is well documented in many studies, however in mostly uncontrolled settings. Symptom remission rates vary in a wide range between 40 and 94%, which reflects the mostly inhomogeneous patient groups.
SummaryPhenotyping of BPS/IC patients is assumed to be the key point to increase efficacy of GAG substitution therapy that should be dedicated to patients with bladder-centric phenotype.